Evommune Inc.
- Biotech or pharma, therapeutic R&D
Evommune is a clinical-stage biotech discovering and developing new ways to treat immune-mediated inflammatory diseases. Our company is creating game-changing science with the goal of delivering therapies that halt disease progression and address disease symptoms.
Our programs are designed to advance therapies for chronic inflammatory diseases in underserved patient populations where a high unmet need remains. We target these pathologies at the source with novel agents that exhibit best-in-class profiles for safety and efficacy, delivering therapeutics for patients that go beyond symptomatic relief.